(Q37386093)

20 August 2017

How to measure hepatic insulin resistance? (English)

1 reference

20 August 2017

1 reference

1 reference

S-P Choukem

1

1 reference

PubMed ID

19195628

20 August 2017

J-F Gautier

series ordinal

2

1 reference

20 August 2017

1 December 2008

1 reference

20 August 2017

Diabetes and Metabolism

1 reference

20 August 2017

34

1 reference

20 August 2017

6 Pt 2

1 reference

20 August 2017

664-673

1 reference

Standards of medical care in diabetes--2007.

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Insulin resistance and pancreatic beta cell failure

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Nuclear magnetic resonance studies of hepatic glucose metabolism in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

ChREBP, a transcriptional regulator of glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Differences in the regulation of adipose tissue and liver lipogenesis by carbohydrates in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

The direct and indirect effects of insulin on hepatic glucose production in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Insulin's effect on the liver: "direct or indirect?" continues to be the question

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Insulin's direct effects on the liver dominate the control of hepatic glucose production

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphoenolpyruvate carboxykinase (GTP) gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

The assessment of insulin resistance in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Insulin sensitivity and its measurement: structural commonalities among the methods

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Evaluation of insulin sensitivity in clinical practice and in research settings

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Use of stable isotopes to study carbohydrate and fat metabolism at the whole-body level

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Use of a novel triple-tracer approach to assess postprandial glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Theory and use of tracers in determining transfer rates in biological systems

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Equations for tracer experiments

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Influences of glucose loading and of injected insulin on hepatic glucose output

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Measurement of size and turnover rate of body glucose pool by the isotope dilution method

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

13C- and 2H-labelled glucose compared for minimal model estimates of glucose metabolism in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Glucose homeostasis and the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Insulin regulation of renal glucose metabolism in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Renal gluconeogenesis: its importance in human glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Mechanism by which metformin reduces glucose production in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974602-0

7 January 2021

10.1016/S1262-3636(08)74602-0

Identifiers

DOI

1 reference

release_cnjve6ioj5c3vmuwm33odt5xu4

20 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cnjve6ioj5c3vmuwm33odt5xu4

24 November 2022

mapped directly with Wikidata item

PubMed ID

19195628

1 reference

PubMed ID

19195628